The role of SPATA2 in TNF signaling, cancer, and spermatogenesis

Valentina Masola1, Nicola Greco1, Pamela Tozzo2

  • 1Department of Biomedical Sciences, University of Padova, Padua, Italy.

Cell Death & Disease
|November 19, 2022
PubMed

Insights

SPATA2 protein is crucial for recruiting CYLD to the TNFR1 signaling complex, promoting TNF-induced necroptosis. Loss of SPATA2 limits this cell death pathway and increases NF-kB activation.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • Necroptosis, a genetically regulated form of necrosis, is an emerging cell death pathway implicated in human disease.
  • Tumor Necrosis Factor (TNF) receptor signaling is a key regulator of cell death, but not all components are fully understood.
  • SPATA2 (Spermatogenesis-associated protein 2) was identified as a critical gene in cellular signaling networks regulating apoptosis and necroptosis.

Purpose of the Study:

  • To investigate the role of SPATA2 in TNF receptor signaling and its impact on necroptosis.
  • To elucidate the mechanism by which SPATA2 influences TNF-induced cell death.
  • To highlight recent findings on SPATA2's function in physiological and pathological contexts.

Main Methods:

  • Cloning and characterization of the Spata2 gene.
  • Analysis of Spata2 gene expression in different tissues.
  • Investigating the effect of Spata2 deletion on male fertility and inhibin α expression.
  • Examining the recruitment of CYLD to the TNFR1 signaling complex.
  • Assessing NF-kB transcriptional activation and TNF-induced necroptosis.

Main Results:

  • SPATA2 is essential for recruiting CYLD to the TNFR1 signaling complex, thereby promoting TNF-induced necroptosis.
  • Loss of SPATA2 leads to increased NF-kB transcriptional activation.
  • SPATA2 deletion in male mice results in increased inhibin α expression and reduced fertility.
  • SPATA2 plays a critical role in limiting TNF-induced necroptosis.

Conclusions:

  • SPATA2 is a key regulator of TNF-induced necroptosis by facilitating CYLD recruitment to the TNFR1 complex.
  • Dysregulation of SPATA2 impacts NF-kB activation and necroptosis, with implications for male fertility.
  • Further research into SPATA2's role in TNF signaling is warranted for understanding disease mechanisms.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Spermatogenesis01:22

Spermatogenesis

Spermatogenesis is a complex process that involves the development of sperm cells from undifferentiated stem cells in the seminiferous tubules of the testes. The process is essential for the production of mature and functional sperm cells that are capable of fertilizing an egg.
The process of spermatogenesis can be divided into mitosis, meiosis, and spermiogenesis. During mitosis, the spermatogonia or stem cells divide to produce two identical daughter cells, type A and B spermatogonia. Type-A...
3.2K